ஜெர்ரி ப்ருங்க News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜெர்ரி ப்ருங்க. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜெர்ரி ப்ருங்க Today - Breaking & Trending Today

Lumira Ventures Closes Two Funds Totalling US$255M

Lumira Ventures Closes Two Funds Totalling US$255M
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.

United States , Al Iskandariyah , British Columbia , Angelini Pharma , Gerry Brunk , Business Development Bank , Ontario Capital Growth Corporation , Healthcare Holdings , Royal Bank , Lumira Ventures , Kensington Capital Partners , Fonds De Solidarit , Northleaf Capital Partners , Teralys Capital , Alexandria Venture Investments , China Grand Pharmaceutical , Amana Global Partners , Managing General Partner , Managing Director , ஒன்றுபட்டது மாநிலங்களில் , பிரிட்டிஷ் கொலம்பியா , ஏஞ்சலினி பார்மா , ஜெர்ரி ப்ருங்க , வணிக வளர்ச்சி வங்கி , ஆஂடேரியொ மூலதனம் வளர்ச்சி நிறுவனம் , சுகாதாரம் ஹோல்டிங்ஸ் ,

Cyrano Therapeutics Raises $12.8 Million to Complete Phase 2 Trial of CYR-064 for the Restoration of

Search jobs
10-Dec-2020
Cyrano Therapeutics Raises $12.8 Million to Complete Phase 2 Trial of CYR-064 for the Restoration of Chronic Smell and Flavor Loss
WASHINGTON, Dec. 10, 2020 /PRNewswire/ Cyrano Therapeutics, a clinical stage regenerative medicine company developing a novel intranasal therapy for smell and flavor restoration, has raised $12.8 million in a Series A financing led by Remiges Ventures and Lumira Ventures, with the participation of additional investors. The funds will be used to complete a Phase 2 clinical trial of the company s lead product, CYR-064, in the U.S. and Europe. As part of the financing, Taka Koda of Remiges Ventures and Gerry Brunk of Lumira Ventures have joined the company s board of directors. ....

District Of Columbia , United States , Robert Henkin , Gerry Brunk , Rick Geoffrion , Cyrano Therapeutics , Remiges Ventures , Lumira Ventures , Taka Koda , Chief Executive Officer Rick Geoffrion , Smell Clinic , மாவட்டம் ஆஃப் கொலம்பியா , ஒன்றுபட்டது மாநிலங்களில் , ஜெர்ரி ப்ருங்க , சைரானோ சிகிச்சை , லுமிரா முயற்சிகள் , தக்கா கோடா , வாசனை சிகிச்சையகம் ,

Cyrano Therapeutics Raises $12.8 Million to Complete Phase 2 Trial of CYR-064 for the Restoration of Chronic Smell and Flavor Loss

Share this article
Share this article
WASHINGTON, Dec. 10, 2020 /PRNewswire/ Cyrano Therapeutics, a clinical stage regenerative medicine company developing a novel intranasal therapy for smell and flavor restoration, has raised $12.8 million in a Series A financing led by Remiges Ventures and Lumira Ventures, with the participation of additional investors. The funds will be used to complete a Phase 2 clinical trial of the company s lead product, CYR-064, in the U.S. and Europe. As part of the financing, Taka Koda of Remiges Ventures and Gerry Brunk of Lumira Ventures have joined the company s board of directors.
The chronic loss of smell and flavor is a condition affecting at least 5% of the population in the U.S. with a similar incidence in Europe and Asia. Influenza, allergic rhinitis and traumatic brain injury are commonly known causes of chronic smell and flavor loss. In the neurodegenerative disease sector, it is also known that 95 percent of Parkinson s pati ....

District Of Columbia , United States , Robert Henkin , Gerry Brunk , Rick Geoffrion , Cyrano Therapeutics , Remiges Ventures , Lumira Ventures , Taka Koda , Chief Executive Officer Rick Geoffrion , Smell Clinic , மாவட்டம் ஆஃப் கொலம்பியா , ஒன்றுபட்டது மாநிலங்களில் , ஜெர்ரி ப்ருங்க , சைரானோ சிகிச்சை , லுமிரா முயற்சிகள் , தக்கா கோடா , வாசனை சிகிச்சையகம் ,